Polyrizon reported an initial statement of beneficial ownership by Eyal Ron, Chief Science Officer. Ron reported direct beneficial ownership of 1,459 ordinary shares. Ron also reported options to purchase 8 ordinary shares at a USD 1,018.3 exercise price. He additionally reported options to purchase 10 ordinary shares at a USD 1,699.3 exercise price.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-029520), on March 18, 2026, and is solely responsible for the information contained therein.